Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers

Taskeen Iqbal Janjua (Korresp. Autor*in), Yuxue Cao, Freddy Kleitz, Mika Linden, Chengzhong Yu, Amirali Popat (Korresp. Autor*in)

Veröffentlichungen: Beitrag in FachzeitschriftReviewPeer Reviewed


Silica nanoparticles (SNP) have gained tremendous attention in the recent decades. They have been used in many different biomedical fields including diagnosis, biosensing and drug delivery. Medical uses of SNP for anti-cancer, anti-microbial and theranostic applications are especially prominent due to their exceptional performance to deliver many different small molecules and recently biologics (mRNA, siRNA, antigens, antibodies, proteins, and peptides) at targeted sites. The physical and chemical properties of SNP such as large specific surface area, tuneable particle size and porosity, excellent biodegradability and biocompatibility make them an ideal drug delivery and diagnostic platform. Based on the available data and the pre-clinical performance of SNP, recent interest has driven these innovative materials towards clinical application with many of the formulations already in Phase I and Phase II trials. Herein, the progress of SNP in biomedical field is reviewed, and their safety aspects are analysed. Importantly, we critically evaluate the key structural characteristics of SNP to overcome different biological barriers including the blood–brain barrier (BBB), skin, tumour barrier and mucosal barrier. Future directions, potential pathways, and target areas towards rapid clinical translation of SNP are also recommended.

FachzeitschriftAdvanced Drug Delivery Reviews
PublikationsstatusVeröffentlicht - Dez. 2023

ÖFOS 2012

  • 210004 Nanomaterialien
  • 301208 Pharmazeutische Technologie